Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ

$10.75

$+0.05

(+0.47%)

Pre-Market

Arcturus Therapeutics Holdings Inc. (ARCT) Live Price Chart

Last updated: ⁦2026-10-23 10:31:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Arcturus Therapeutics Holdings Inc. (ARCT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $10.75, with a market capitalization of $314.64M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.50 to $17.96. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$314.64M
Open	$10.70
Day's High	$129.71
Day's Low	$4.11
Previous Close	$10.73
Volume	348.00
Average Volume	955.32K
P/E Ratio	--
52-Week High	$17.96
52-Week Low	$5.50
Dividend Yield	--
Earnings Date	--

Arcturus Therapeutics Holdings Inc. (ARCT) Pre-Market Stock Price

Arcturus Therapeutics Holdings Inc. (ARCT) is trading at $10.75 in pre-market trading as of 2026-10-23 10:20:00, up 0.19% ($0.02) from the previous close of $10.73

Pre-market trading shows how investors are pricing ARCT before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Arcturus Therapeutics Holdings Inc. (ARCT) 7-Day Stock Price Change

Over the past seven days, Arcturus Therapeutics Holdings Inc. (ARCT) moved from $11.12 to $10.75, representing a decline of 3.33% ($0.37).

The stock traded between $10.25 and $12.05 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 604.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ARCT 52-Week Price Position

Position in Range: 42.1%

52W Low$5.50

52W High$17.96

ARCT is currently trading at $10.75, placing it 42.1% of the way from its 52-week low of $5.50 to its 52-week high of $17.96. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arcturus Therapeutics Holdings Inc. (ARCT)?

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Arcturus Therapeutics Holdings Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	111
Exchange	NASDAQ
Company Website	https://www.arcturusrx.com

How to Buy Arcturus Therapeutics Holdings Inc. (ARCT) Stock on MEXC

Eligible investors can buy real shares of Arcturus Therapeutics Holdings Inc. (ARCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ARCT and Place Your Order

Open the RealStocks trading page and search for ARCT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arcturus Therapeutics Holdings Inc. (ARCT) stock price today?

Arcturus Therapeutics Holdings Inc. (ARCT) is currently trading at $ 10.75, up 0.19% ($0.02) from the previous close of $ 10.73. Intraday prices update in real time during regular trading hours.

2.Is ARCT stock going up or down today?

As of 2026-10-23 10:20:00, ARCT is trading at $ 10.75, up 0.19% ($0.02) from its previous close of $ 10.73. The stock has traded between $ 4.11 and $ 129.71 during today’s regular session. Past price movements do not guarantee future results.

3.What is ARCT pre-market price?

As of 2026-10-23 10:20:00, ARCT is trading at $ 10.75 in pre-market trading, up 0.19% ($0.02) from the previous close of $ 10.73. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ARCT after-hours price?

As of 2026-10-23 10:20:00, ARCT is trading at $ 10.70 in after-hours trading, down 0.28% ($0.03) from the regular-session close of $ 10.73. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ARCT stock trading now?

ARCT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ARCT sit relative to its 52-week high and low?

Over the past 52 weeks, ARCT has traded between a low of $ 5.50 and a high of $ 17.96. At $ 10.75, the stock is positioned 42.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arcturus Therapeutics Holdings Inc. in?

Arcturus Therapeutics Holdings Inc. (ARCT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arcturus Therapeutics Holdings Inc.'s market capitalization and where is it listed?

Arcturus Therapeutics Holdings Inc. is listed on the NASDAQ exchange with a market capitalization of $ 314.64M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ARCT valued in terms of P/E ratio and EPS?

ARCT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arcturus Therapeutics Holdings Inc. pay a dividend?

Arcturus Therapeutics Holdings Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.